In view of the above, the Commission considers that the preparation of Lactiplantibacillus plantarum DSM 11520 satisfies the conditions provided for in Article 5 of Regulation (EC) No 1831/2003. Accordingly, the use of that preparation should be authorised. In addition, the Commission considers that appropriate protective measures should be taken to prevent adverse effects on the health of the users of the additive.
Recital 6, Regulation (EU) 2024/1104
In forcesince 17 Apr 2024